Page last updated: 2024-12-06

girolline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

girolline: has antineoplastic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID362388
CHEMBL ID1982734
SCHEMBL ID9862352
MeSH IDM0518433

Synonyms (11)

Synonym
nsc626159
nsc-626159
girolline
1h-imidazole-4-methanol, 2-amino-.alpha.-(2-amino-1- chloroethyl)-
NCI60_008277
3-amino-1-(2-amino-1h-imidazol-5-yl)-2-chloropropan-1-ol
SCHEMBL9862352
CHEMBL1982734
girolline; rp 49532
Q15634136
DTXSID00869538
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]